Biogen Inc. (BIIB) Financials
BIIB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 32.1 billion | 13.2 billion |
| March 31, 2026 | 29.5 billion | 10.8 billion |
| Dec. 31, 2025 | 29.4 billion | 11.2 billion |
| Sept. 30, 2025 | 29.2 billion | 11.0 billion |
BIIB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 489.8 million | -84.0 million |
| March 31, 2026 | 696.7 million | 84.0 million |
| Dec. 31, 2025 | 555.9 million | 59.6 million |
| Sept. 30, 2025 | 1.2 billion | 75.3 million |
BIIB Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | -319.5 million |
| March 31, 2026 | 319.5 million |
| Dec. 31, 2025 | -48.9 million |
| Sept. 30, 2025 | 466.5 million |
BIIB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.3 billion | 7.3 billion | 264.8 million |
| March 31, 2026 | 4.3 billion | 6.3 billion | 273.4 million |
| Dec. 31, 2025 | 3.8 billion | 6.6 billion | 290.4 million |
| Sept. 30, 2025 | 4.0 billion | 6.3 billion | 305.0 million |
BIIB Shares Outstanding
BIIB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 40.9 million | 495.6 million | 709.7 million | - |
| March 31, 2026 | 51.2 million | 573.0 million | 607.3 million | - |
| Dec. 31, 2025 | 43.9 million | 509.3 million | 683.0 million | - |
| Sept. 30, 2025 | 46.2 million | 369.6 million | 594.8 million | - |
BIIB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 2.7 billion | 1.2 billion |
| March 31, 2026 | 2.5 billion | 661.0 million |
| Dec. 31, 2025 | 2.3 billion | 496.3 million |
| Sept. 30, 2025 | 2.5 billion | 876.6 million |
BIIB Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BIIB
Price: $225.71
52 week price:
Payout Ratio Range:
Earnings Per Share: 5.63 USD
P/E Ratio: 37.02
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 789100
Ebitda: 1.6 billionMarket Capitalization: 32.9 billion